SUMO-modification and elimination of the active DNA demethylation enzyme TDG in cultured human cells

Biochem Biophys Res Commun. 2014 May 9;447(3):419-24. doi: 10.1016/j.bbrc.2014.04.004. Epub 2014 Apr 12.

Abstract

Thymine DNA glycosylase (TDG) is a base excision repair enzyme that interacts with the small ubiquitin-related modifier (SUMO)-targeted ubiquitin E3 ligase RNF4 and functions in the active DNA demethylation pathway. Here we showed that both SUMOylated and non-modified forms of endogenous TDG fluctuated during the cell cycle and in response to drugs that perturbed cell cycle progression, including hydroxyurea and nocodazole. Additionally, we detected a SUMOylation-independent association between TDG and RNF4 in vitro as well as in vivo, and observed that both forms of TDG were efficiently degraded in RNF4-depleted cells when arrested at S phase. Our findings provide insights into the in vivo dynamics of TDG SUMOylation and further clarify the TDG-RNF4 interaction.

Keywords: Cell cycle; DNA demethylation; Ring finger protein 4 (RNF4); SUMO-targeted ubiquitin ligase (STUbL); Small ubiquitin-related modifier (SUMO); Thymine DNA glycosylase (TDG).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Cycle / drug effects
  • Cells, Cultured
  • DNA Methylation*
  • Humans
  • Hydroxyurea / pharmacology
  • Mutation
  • Nocodazole / pharmacology
  • Nuclear Proteins / metabolism*
  • Small Ubiquitin-Related Modifier Proteins / metabolism*
  • Sumoylation*
  • Thymine DNA Glycosylase / genetics
  • Thymine DNA Glycosylase / metabolism*
  • Transcription Factors / metabolism*

Substances

  • Nuclear Proteins
  • RNF4 protein, human
  • Small Ubiquitin-Related Modifier Proteins
  • Transcription Factors
  • Thymine DNA Glycosylase
  • Nocodazole
  • Hydroxyurea